This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches features and perspectives
Published on: Feb 10, 2014
Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches: features and perspectives
There is growing recognition that the current research-and-development (R&D) and innovation-regulation ecosystem could be made more efficient to stimulate and support access to innovative therapies for those patients with rare, life-threatening diseases for which there are no adequate licensed therapies.
Emmanuelle Voisin, David Uguen
2014 – Orphanet Journal of Rare Diseases
Download the full resource now
Fill in the form to download the content